ClinicalTrials.Veeva

Menu

PracticeGround: Transforming Training and Delivery of Mental Health EBPs

University of Washington logo

University of Washington

Status

Completed

Conditions

Insomnia
Depression
Suicide

Treatments

Behavioral: Care-as-Usual Psychotherapy
Behavioral: Behavioral Activation for Depression, Cognitive Behavior Therapy for Insomnia, Collaborative Assessment and Management of Suicidality

Study type

Interventional

Funder types

Industry

Identifiers

NCT02314624
2R44MH093993-02A1

Details and patient eligibility

About

The ultimate goal is to facilitate the delivery of empirically supported treatments (ESTs) for mental disorders and to improve client mental health outcomes. Toward this end, this Phase II SBIR proposal seeks to complete the development and testing of PracticeGround, a comprehensive software system designed to integrate with electronic health records, and that contains multiple methods of training clinicians in ESTs and delivering ESTs to clients, continuous progress monitoring of client outcomes, and clinical support tools to guide clinicians and clients through delivery of the necessary EST. The investigators will conduct an 18-week randomized controlled trial (N=80) comparing PracticeGround (n=40) to care-as-usual (n=40) in depressed outpatient clients. PracticeGround clinicians will have full access to the software. Study clinicians and clients will be assessed once every six weeks (baseline, 6, 12, and 18 weeks). To ensure generalizability of findings, the investigators will not control for natural therapy variations (e.g.,session frequency, medication use, etc.). Primary outcomes include: depression, psychological distress, treatment satisfaction (clients and clinicians), and treatment drop out. Secondary clinician outcomes include: extent of PracticeGround use with clients across clinicians' caseload.

Enrollment

142 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

PATIENTS

Inclusion Criteria:

  • Meets DSM-IV criteria for MDD and/or DD
  • Obtains a score of 11 or greater on the PHQ-9
  • Currently receiving psychosocial treatment for depression by a study-participant clinician
  • Payment-eligible to receive at least 12 weeks of additional psychosocial treatment

Exclusion Criteria:

  • Current diagnosis of bipolar disorder or another psychotic disorder
  • Active mania
  • Current diagnosis of alcohol and/or drug dependence
  • At imminent risk of suicide (as deemed by their clinician).

PROVIDERS

Inclusion Criteria:

  • English speaker
  • 18 years or older
  • Currently licensed mental health treatment provider (or a therapist working towards licensure under direct supervision of licensed mental health treatment provider)
  • Have an office with access to internet
  • Have access to computer with sound card and/or tablet and printer
  • Capacity to accept new patients seeking treatment for depressive symptoms

Exclusion Criteria:

  • (PILOT ONLY) Receiving training for an evidence based treatment for depression, including behavioral activation, interpersonal therapy, cognitive/cognitive-behavioral therapy, mindfulness-based cognitive therapy or cognitive behavioral analysis system of psychotherapy
  • Participated in the Field Test for WILLOW
  • Is not comfortable/savvy with technology (by answering "I get easily frustrated and usually walk away from it" to the question "Which response best matches how you typically respond to complicated problems you encounter when using a new app, computer, or technology for the first time?"; answering "I am not comfortable and/or do not enjoy technology, particularly new forms of technology. I avoid the use of technology as much as is realistically possible." to the question "How technologically savvy/skilled are you?")
  • Does not have a feasible office set up for using a computer in therapy

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

142 participants in 2 patient groups

WILLOW
Experimental group
Description:
Clinicians have access to WILLOW's dynamic progress monitoring, clinical decision support, rich visual displays of client outcomes, online training modules in ESTs, just-in-time training for guided real-time assistance in delivering ESTs, educational videos, and a client portal
Treatment:
Behavioral: Behavioral Activation for Depression, Cognitive Behavior Therapy for Insomnia, Collaborative Assessment and Management of Suicidality
Treatment-as-Usual
Active Comparator group
Description:
Usual care without access to WILLOW.
Treatment:
Behavioral: Care-as-Usual Psychotherapy

Trial documents
3

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems